Summaries by Inventor Ghobadi, Armin
Anti-FCRL5 Chimeric Antigen Receptor (CAR) Targeting Multiple Myeloma
DiPersio, John ; Ghobadi, Armin ; O'Neal, Julie ; Ritchey, Julie
T-020082
Ances, Beau ; Butt, Omar ; DiPersio, John ; Ghobadi, Armin
T-019528
DiPersio, John ; Ghobadi, Armin ; O'Neal, Julie ; Ritchey, Julie
T-020082
— Published Date: 5/13/2025 Value Proposition: An innovative therapy leveraging unique chimeric antigen receptors (CAR) to specifically target Fc receptor-like 5 (FCRL5), enabling the precise elimination of FCRL5-expressing cells to treat multiple myeloma and other cancers. Technology Description …
Predictive biomarker for CAR T-associated neurotoxicityAnces, Beau ; Butt, Omar ; DiPersio, John ; Ghobadi, Armin
T-019528
— Technology Description: Researchers at Washington University in St. Louis have developed a biomarker screening assay to predict which patients receiving CAR T cell therapy will experience neurotoxicity. Patients can be screened well in advance of receiving the T cell therapy with a simple serum as…
